# Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism

> **NCT04790370** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 544 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Anticoagulation with heparin
- **DEVICE:** EkoSonicTM Endovascular System

## Key facts

- **NCT ID:** NCT04790370
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-02
- **Primary completion:** 2025-07-31
- **Final completion:** 2026-08
- **Target enrollment:** 544 (ACTUAL)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790370, "Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04790370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*